Skip to content

Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery

Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02276911
Enrollment
6
Registered
2014-10-28
Start date
2015-03-01
Completion date
2017-07-17
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spondylosis, Lumbar Spondylosis

Brief summary

A prospective, randomized, placebo controlled, double-blinded study at a single institution.

Detailed description

Pain medicine literature and the principal investigator's anecdotal experience in posterior cervical and lumbar instrumented spine surgery suggest that pre-incisional IV ibuprofen significantly reduces postoperative pain without increasing surgical complications or fusion rate, which leads to earlier ambulation, less dependence on narcotic medications, shorter hospital stays, and earlier return to work. The purpose of this study is to assess if these anecdotal findings hold true in a randomized clinical trial of patients with cervical or lumbar spondylosis, who are undergoing decompression and instrumented fusion of the spine.

Interventions

DRUGIbuprofen
OTHERnormal saline

Sponsors

St. Joseph's Hospital and Medical Center, Phoenix
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years of age * Able to give consent * Diagnosed with spondylosis, stenosis, and/or instability of the cervical spine * Diagnosed with spondylosis, stenosis, and/or instability of the lumbar spine * Require a posterior decompression with internal fixation * Likely to complete the trial

Exclusion criteria

* Patients with previous surgery at the treated spine segment * Women who are pregnant or plan to become pregnant during the study period Renal/liver disease * Anemia; coagulopathy * Thrombocytopenia (\<30,000) * Coronary artery disease * Previous coronary artery bypass graft (CABG) * Patients taking Coumadin, Plavix, Lithium, or ACE-inhibitors plus Lasix; non-steroidal anti-inflammatory drug (NSAID) hypersensitivity * Gastric ulcers * Recent stroke * Traumatic brain injury, or intracranial surgery

Design outcomes

Primary

MeasureTime frameDescription
Change in pain levelpre-operative, 1-3 weeks post-operative, 6 months post-operativeVisual Analog Scale (VAS) scores at rest and with movement, Macqill Pain Questionnaire scores, and total morphine and morphine equivalents used during hospital admission.
Change in overall health/functionpre-operative, 1-3 weeks post-operative, 6 months post-operativeSF-36 scores, total length of hospital stay, time to ambulation, and time to return to work.
Fusion rates6 month post-operativeAssessed by plain x-rays or CT scans.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026